Key TakeawaysElevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.Both earnings and revenue exceeded analysts' forecasts on what CEO Gail Boudreaux called "tangible progress in improving our operations."Elevance booted its quarterly dividend $0.08 to $1.71 per share. Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on ...

For the quarter ended December 2024, Elevance Health (ELV) reported revenue of $44.99 billion, up 6% over the same period last year. EPS came in at $3.84, compared to $5.62 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $44.67 billion, representing a surprise of +0.71%. The company delivered an EPS surprise of +1.05%, with the consensus EPS estimate being $3.80.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

Michael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. He has finance experience across multiple industries, including Telecom, Media and Entertainment, Hospitality, and Construction. He founded F9 Finance, a website that helps Finance professionals accelerate their careers; and simplifies Fina ...

E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS; SETS FULL YEAR 2025 OUTLOOK Indianapolis, IN - January 23, 2025 - Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond healthcare, we deliver value to the members and care providers we serve by ensuring simple, affordable, and accessible care. Our fourth quarter results demonstrate tangible progress ...

Elevance Health, Inc. (ELV) is set to report fourth-quarter 2024 results on Jan. 23, 2024, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $3.82 per share on revenues of $44.67 billion. See the Zacks Earnings Calendar to stay ahead of market-making news.The fourth-quarter earnings estimate remained stable over the past 30 days. However, the bottom-line projection indicates a year-over-year decline of 32%. The Zacks Consensus Estimate for ...

Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $3.82 per share in its upcoming release, pointing to a year-over-year decline of 32%. It is anticipated that revenues will amount to $44.67 billion, exhibiting an increase of 5.2% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial ...

Company Overview - Elevance Health (NYSE: ELV) is a major health insurance provider in the United States, serving approximately 47 million members [1] - The company appears to be in strong financial condition [1] Stock Performance - Elevance Health's stock has significantly outperformed the overall market [1] Author Background - The author holds a Ph.D. in engineering and has expertise in acoustics and noise research [2] - The author is passionate about finance and stock investment, with a focus on capital appreciation opportunities [2] - The author's investment strategy includes purchasing high-quality undervalued companies and reasonably priced growth companies [2] - The author also invests in dividend-paying stocks that are good companies and correctly priced [2] Note: The content does not provide specific financial data, percentage changes, or detailed industry analysis, so those aspects are not included in the summary

U.S. health benefits company Elevance Health, Inc. (ELV) shares have declined 29.6% quarter to date, underperforming its industry and the S&P 500 Index. Closing at $366.48 on Thursday, near its 52-week low of $362.21, the company’s current share price seems an excellent opportunity to build a position in a renowned company. After all, you would much rather buy closer to the low than the high, right?Elevance Health, headquartered in Indianapolis, IN, has a market capitalization of $84.9 billion. Its peers, U ...

SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Elevance Health Inc. (NASDAQ: ELV) to determine whether certain Elevance officers and directors violated securities laws and breached fiduciary duties to shareholders. Elevance is a healthcare company that supports consumers, families, and communities across the entire care journey. What Now: If you own shares of Elevance Health Inc. and have lost money in your investment, contact us for more information ab ...

Elevance Health (NYSE: ELV ) is one of the largest healthcare insurers in the US. During FY23, they had 45 million members and had served over 115 million people. They have enjoyed revenue growth of 9.1% over the past 10 years and 13.7% EPSWe use Cash Flow Returns On Investment based DCF valuation tools provided by our affiliate company, ROCGA Research.With over 20 years of experience in investment analysis, we are actively seeking out undervalued and quality companies.ROCGA Research is an online platform t ...